Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
CuraFi
AddedFeb 15, 2024
UpdatedJun 18, 2026
CuraFi

CuraFi

CuraFi: A healthcare management firm offering specialty infusion services and software for complex conditions.

HQ
San Francisco, CA, US
Founded
2022
Overview
Compare
Fundraising
Employees
Website

CuraFi, founded with a mission to enhance healthcare delivery for patients with complex conditions, specializes in providing specialty infusion services. The company offers a comprehensive management platform that enables independent providers to improve continuity of care while capturing new revenue streams. CuraFi's services cater to various stakeholders, including Accountable Care Organizations (ACOs), biopharma companies, and payors, focusing on expanding access to specialty medications and managing complex disease states.

Notable figures affiliated with CuraFi include experienced healthcare professionals and industry leaders who contribute to its strategic direction. The company has achieved significant milestones, such as developing an all-in-one solution for in-office specialty medication delivery and a software platform for managing prior authorizations, drug procurement, and billing. CuraFi's impact is evident in its ability to streamline healthcare processes, improve patient outcomes, and support healthcare providers in offering specialized care efficiently.

CuraFi - Similar Companies

Endue logo

Endue

enduesoftware.com

Cura OS logo

Cura OS

curaos.com

Medcurio logo

Medcurio

medcurio.com

Cura Digital Health Solutions logo

Cura Digital Health Solutions

CuraPatient logo

CuraPatient

curapatient.com

Curie.Bio logo

Curie.Bio

curie.bio

Curantis Solutions logo

Curantis Solutions

Curvo Labs logo

Curvo Labs

curvolabs.com

Local Infusion logo

Local Infusion

Infusion for Health logo

Infusion for Health

Medix Infusion logo

Medix Infusion

medixinfusion.com

eBlu Solutions logo

eBlu Solutions

eblusolutions.com

CuriMeta logo

CuriMeta

curimeta.com

HealerPlus logo

HealerPlus

healerplus.com

Emissary Health logo

Emissary Health

CuraFi - Quick Facts

Who are CuraFi's competitors?

Companies similar to CuraFi include Endue, Cura OS, Medcurio and Cura Digital Health Solutions.

When was CuraFi founded?

CuraFi was founded in 2022.

Where is CuraFi's headquarters located?

CuraFi's headquarters is located in San Francisco, CA, US.

When was CuraFi's last funding round?

CuraFi's most recent funding round was for $5M (USD) in February 2023.

How much has CuraFi raised to-date?

As of Feb 19, 2023, CuraFi has raised a total of $6.8M (USD).

How many employees does CuraFi have?

CuraFi has 1 employee as of Feb 4, 2024.

CuraFi - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
  • Healthcare
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Healthcare Software
  • Infusion Services
Tags
  • Healthtech
  • Providers
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 5 more industry codes
NAICS
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
  • 623000Nursing and Residential Care Facilities
SIC
  • 8060Hospitals